pone.0224253.g005.tif (840.82 kB)

Cell proliferation of PDX-derived CRC cell lines treatment combinations.

Download (840.82 kB)
figure
posted on 24.10.2019, 17:29 by Heather F. Sinner, Jeremy Johnson, Piotr G. Rychahou, David S. Watt, Yekaterina Y. Zaytseva, Chunming Liu, B. Mark Evers

(A) Western blot analysis of PDX-derived CRC cell lines treated with 10μM FND-4b, 5μM PI-103, and 100nM SN-38, alone and in combination versus untreated control (media alone) for 24h duration. β-actin was used as a loading control. The images are representative of three independent experiments. In all CRC cell lines mono- or dual-treatment with FND-4b resulted in decreased cyclin D1 expression. (B) SRB Cytotoxicity Assays of PDX-derived CRC cell lines treated with 10μM FND-4b, 5μM PI-103, and 100nM SN-38, alone and in combination for 144h duration. Graphic representations are the mean ± SD plotted as a percentage relative to untreated control; each measurement was performed with 5 replicates. *p<0.0001 vs. control, #p<0.01 vs. FND-4b alone, and +p<0.05 vs. SN-38 alone.

History

Licence

Exports